Tags » Truth On The Market

Understanding government negotiation of Medicare drug prices

In a weekend interview with the Washington Post, Donald Trump vowed to force drug companies to negotiate directly with the government on prices in Medicare and Medicaid.  951 more words

Truth On The Market

FTC Economists’ Paper Discredits Claims of Inappropriately “Weak” Merger Enforcement

During 2016 it became fashionable in certain circles to decry “lax” merger enforcement and to call for a more aggressive merger enforcement policy (see, for example, … 449 more words

Antitrust

What Will Trump Antitrust Be Like? Come to Heritage on January 24 and Find Out

During a presidential transition, it is an old Washington parlor game to discuss public policy tweaks and personnel changes, with speculation often focusing on former political appointees who are linked to the new President.  202 more words

Truth On The Market

@geoffmanne & @neilturkewitz: Public Knowledge’s Lonely Echo Chamber of Copyright Advocacy

Yesterday the Chairman and Ranking Member of the House Judiciary Committee issued the first set of policy proposals following their long-running copyright review process. These proposals were principally aimed at ensuring that the IT demands of the Copyright Office were properly met so that it could perform its assigned functions, and to provide adequate authority for it to adapt its policies and practices to the evolving needs of the digital age.

259 more words
In A Goolag State Of Mind

Supreme Court’s Samsung v. Apple Decision and the Status of Design Patents

On December 6 the U.S. Supreme Court handed down its much anticipated decision in Samsung Electronic Co. v. Apple Inc.  The opinion deferred for another day clarification of key policy questions raised by the design patent system. 560 more words

Truth On The Market

What's next for the pharmaceutical industry?

On November 9, pharmaceutical stocks soared as Donald Trump’s election victory eased concerns about government intervention in drug pricing. Shares of Pfizer rose 8.5%, Allergan PLC was up 8%, and biotech Celgene jumped 10.4%. 589 more words

Truth On The Market

December 6 Heritage Foundation Program on IP Rights, Competition, and Due Process Overseas: Attend or Watch

In recent years, aggressive antitrust enforcement overseas has increasingly targeted some of America’s most successful and innovative companies, such as Apple, Google, Microsoft, and Qualcomm.  Inadequate foreign due process and insufficient protection for American intellectual property rights are a feature of many foreign antitrust actions, which threaten to undermine key American producers – harming U.S. 80 more words

Truth On The Market